财新传媒
财新英文 > 要闻 > 正文

In Depth: Why China Still Doesn’t Have an mRNA Shot

By Zhao Jinzhao, Jiang Moting, Chen Pengduo and Han Wei
2022年07月14日 18:30
In a race to develop advanced Covid inoculations, Chinese vaccine-makers lack technical expertise, ingredients, production equipment and delivery system
Researchers show the trial process for developing an mRNA vaccine for Covid 19 in Shanghai in February 2020. Photo: VCG

As the fast-evolving coronavirus tests scientists’ capacity to develop more-effective vaccines, drugmakers in China are scrambling to catch up with the most advanced technology for producing more powerful shots to better protect the world’s largest population.

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

版面编辑:喻竹杨洋
财新微信